HEPATITIS-C VIRAL COMPLEXITY DETECTED BY SINGLE-STRAND CONFORMATION POLYMORPHISM AND RESPONSE TO INTERFERON THERAPY

被引:105
作者
MORIBE, T
HAYASHI, N
KANAZAWA, Y
MITA, E
FUSAMOTO, H
NEGI, M
KANESHIGE, T
IGIMI, H
KAMADA, T
UCHIDA, K
机构
[1] OSAKA UNIV, SCH MED, DEPT MED 1, SUITA, OSAKA 565, JAPAN
[2] SHIONOGI & CO LTD, SHIONOGI BIOMED LABS, DEPT DIAGNOST SCI, OSAKA 553, JAPAN
关键词
D O I
10.1016/0016-5085(95)90452-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Hepatitis C virus (HCV) genome heterogeneity by sequence analysis in association with interferon (IFN) inefficacy has been reported. This study was performed to establish a convenient method for detecting the HCV quasispecies complexity and to determine the correlation between the complexity and the responsiveness to IFN therapy in patients with chronic hepatitis C. Methods: The quasispecies complexity of HCV hypervariable region 1 in patients treated with IFN-alpha was analyzed by polymerase chain reaction-mediated single-strand conformation polymorphism (SSCP). Results: Seven of 25 patients (28%) with low complexity (SSCP band number of less than or equal to 2) were HCV RNA negative after treatment, whereas in 24 patients with high complexity (SSCP band number of greater than or equal to 3), the response to IFN was almost insignificant because only 1 patient (4.5%) remained HCV RNA negative after treatment (P < 0.05). Among type 1b patients, IFN therapy was only effective for patients with low amounts of HCV RNA (less than or equal to 10(7.5) copies/mL serum) and low complexity. In contrast, most type 2a patients tended to respond to the therapy with exceptions being those with high amounts of HCV RNA and high complexity. Conclusions: The complexity of the hypervariable region 1 quasispecies may be a factor for predicting IFN inefficacy in patients with chronic hepatitis C.
引用
收藏
页码:789 / 795
页数:7
相关论文
共 21 条
  • [1] TREATMENT OF CHRONIC HEPATITIS-C WITH RECOMBINANT INTERFERON-ALFA - A MULTICENTER RANDOMIZED, CONTROLLED TRIAL
    DAVIS, GL
    BALART, LA
    SCHIFF, ER
    LINDSAY, K
    BODENHEIMER, HC
    PERRILLO, RP
    CAREY, W
    JACOBSON, IM
    PAYNE, J
    DIENSTAG, JL
    VANTHIEL, DH
    TAMBURRO, C
    LEFKOWITCH, J
    ALBRECHT, J
    MESCHIEVITZ, C
    ORTEGO, TJ
    GIBAS, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (22) : 1501 - 1506
  • [2] RECOMBINANT INTERFERON-ALFA THERAPY FOR CHRONIC HEPATITIS-C - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    DIBISCEGLIE, AM
    MARTIN, P
    KASSIANIDES, C
    LISKERMELMAN, M
    MURRAY, L
    WAGGONER, J
    GOODMAN, Z
    BANKS, SM
    HOOFNAGLE, JH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (22) : 1506 - 1510
  • [3] THE QUASISPECIES (EXTREMELY HETEROGENEOUS) NATURE OF VIRAL-RNA GENOME POPULATIONS - BIOLOGICAL RELEVANCE - A REVIEW
    DOMINGO, E
    MARTINEZSALAS, E
    SOBRINO, F
    DELATORRE, JC
    PORTELA, A
    ORTIN, J
    LOPEZGALINDEZ, C
    PEREZBRENA, P
    VILLANUEVA, N
    NAJERA, R
    VANDEPOL, S
    STEINHAUER, D
    DEPOLO, N
    HOLLAND, J
    [J]. GENE, 1985, 40 (01) : 1 - 8
  • [4] DETECTION OF HEPATITIS-C VIRUS-RNA IN SERUM OF PATIENTS WITH CHRONIC HEPATITIS-C TREATED WITH INTERFERON-ALPHA
    HAGIWARA, H
    HAYASHI, N
    MITA, E
    UEDA, K
    TAKEHARA, T
    KASAHARA, A
    FUSAMOTO, H
    KAMADA, T
    [J]. HEPATOLOGY, 1992, 15 (01) : 37 - 41
  • [5] QUANTITATIVE-ANALYSIS OF HEPATITIS-C VIRUS-RNA IN SERUM DURING INTERFERON ALFA THERAPY
    HAGIWARA, H
    HAYASHI, N
    MITA, E
    TAKEHARA, T
    KASAHARA, A
    FUSAMOTO, H
    KAMADA, T
    [J]. GASTROENTEROLOGY, 1993, 104 (03) : 877 - 883
  • [6] HYPERVARIABLE REGIONS IN THE PUTATIVE GLYCOPROTEIN OF HEPATITIS-C VIRUS
    HIJIKATA, M
    KATO, N
    OOTSUYAMA, Y
    NAKAGAWA, M
    OHKOSHI, S
    SHIMOTOHNO, K
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 175 (01) : 220 - 228
  • [7] TREATMENT OF CHRONIC NON-A,NON-B HEPATITIS WITH RECOMBINANT HUMAN ALPHA-INTERFERON - A PRELIMINARY-REPORT
    HOOFNAGLE, JH
    MULLEN, KD
    JONES, DB
    RUSTGI, V
    DIBISCEGLIE, A
    PETERS, M
    WAGGONER, JG
    PARK, Y
    JONES, EA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (25) : 1575 - 1578
  • [8] INFLUENCE OF VIRAL QUASI-SPECIES ON EFFECTIVENESS OF INTERFERON THERAPY IN CHRONIC HEPATITIS-C PATIENTS
    KANAZAWA, Y
    HAYASHI, N
    MITA, E
    LI, TC
    HAGIWARA, H
    KASAHARA, A
    FUSAMOTO, H
    KAMADA, T
    [J]. HEPATOLOGY, 1994, 20 (05) : 1121 - 1130
  • [9] MARKED SEQUENCE DIVERSITY IN THE PUTATIVE ENVELOPE PROTEINS OF HEPATITIS-C VIRUSES
    KATO, N
    OOTSUYAMA, Y
    TANAKA, T
    NAKAGAWA, M
    NAKAZAWA, T
    MURAISO, K
    OHKOSHI, S
    HIJIKATA, M
    SHIMOTOHNO, K
    [J]. VIRUS RESEARCH, 1992, 22 (02) : 107 - 123
  • [10] SIGNIFICANCE OF SERUM HEPATITIS-C VIRUS-RNA LEVELS IN CHRONIC HEPATITIS-C
    LAU, JYN
    DAVIS, GL
    KNIFFEN, J
    QIAN, KP
    URDEA, MS
    CHAN, CS
    MIZOKAMI, M
    NEUWALD, PD
    WILBER, JC
    [J]. LANCET, 1993, 341 (8859) : 1501 - 1504